JP Stock MarketDetailed Quotes
2160 GNI Group
- 3025
- -65-2.10%
20min DelayMarket Closed Nov 1 15:00 JST
151.48BMarket Cap18.27P/E (Static)
3040High2961Low728.70KVolume3020Open3090Pre Close2.19BTurnover386552wk High1.55%Turnover Ratio50.08MShares153752wk Low137.12EPS TTM142.68BFloat Cap4070Historical High18.27P/E (Static)47.17MShs Float13Historical Low165.56EPS LYR2.56%Amplitude--Dividend TTM4.11P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees840
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Ryosuke Matsui
- Director
- --
- Thomas Eastling
- Director
- --
- Hideaki Sashiwa
- Independent Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Zhang Ping
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data